July 8, 2024
Video
TCTMD's Quick Takes: Amole Ojo
05:20
Digoxin’s risks in HFrEF patients with ICDs are well-known, but the magnitude may surprise, Amole Ojo, MD, explains.
Related News
![Long-term Digoxin Use Linked to VT/VF Risk in HF Patients](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/styles/related_news/public/2024-06/Long-term%20Digoxin%20Use%20Linked%20to%20VTVF%20Risk%20in%20HF%20Patients.jpeg?itok=Oq7zNgmn)